NCT07717242
- Conditions
- Bladder Cancer, Bladder Urothelial Carcinoma, Carcinoma, +14 more
- Locations
-
- Sun Yat-sen Memorial Hospital Guangzhou, Guangdong, China
Clinical trial condition
Carcinoma, Transitional Cell
Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.
430 public trials
126 recruiting studies
Carcinoma, Transitional Cell trial results
Recruiting
Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer
NCT06356155
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
- Locations
-
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
Recruiting
Registry Platform Urologic Cancer
NCT03374267
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- Multiple sites, Germany Multiple Locations, Germany
NCT06695845
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +64 more
- Locations
-
- Arizona Oncology Associates, PC - NAHOA Prescott, Arizona, United States
- Rocky Mountain Cancer Center Littleton, Colorado, United States
- Florida Cancer Specialists - South Fort Myers, Florida, United States
- Florida Cancer Specialists - Lake Nona Orlando, Florida, United States
NCT07169734
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Transitional Cell, +19 more
- Locations
-
- Mayo Clinic Comprehensive Cancer Center Phoenix, Arizona, United States
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- Yale Comprehensive Cancer Center New Haven, Connecticut, United States
- The University of Chicago Medical Center - Oncology Chicago, Illinois, United States
NCT06394869
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
- Locations
-
- Urology Centers of Alabama Homewood, Alabama, United States
- Urology Associates of Mobile Mobile, Alabama, United States
- Urology Associates of Central California Fresno, California, United States
- Urology Group of Southern California Los Angeles, California, United States
Recruiting
Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma Diagnosis
NCT07614594
- Conditions
- Bladder Cancer (BC), Carcinoma, Carcinoma, Transitional Cell, +19 more
- Locations
-
- Henan Provincial People's Hospital Zhengzhou, Henan, China
NCT06101290
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +23 more
- Locations
-
- University of California, Davis Sacramento, California, United States
NCT07673016
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +21 more
- Locations
-
- Urology San Diego Oceanside, California, United States
- Genesis Research, LLC San Diego, California, United States
- Urology Associates of Silicon Valley San Jose, California, United States
- UroPartners, LLC Chicago, Illinois, United States
Recruiting
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer
NCT07484022
- Conditions
- Advanced Urothelial Cancer, Carcinoma, Carcinoma, Transitional Cell, +7 more
- Locations
-
- City of Hope Duarte, California, United States
- COH Lennar Irvine, California, United States
- Orlando Health Orlando, Florida, United States
- COH Atlanta Tucker, Georgia, United States